Cargando…
TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance
Transforming growth factor-β (TGF-β) is major inducer of epithelial to mesenchymal transition (EMT), which associates with cancer cell metastasis and resistance to chemotherapy and targeted drugs, through both transcriptional and non-transcriptional mechanisms. We previously reported that in cancer...
Autores principales: | Tripathi, Veenu, Shin, Jee-Hye, Stuelten, Christina H., Zhang, Ying E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486402/ https://www.ncbi.nlm.nih.gov/pubmed/30626936 http://dx.doi.org/10.1038/s41388-018-0655-8 |
Ejemplares similares
-
Hypoxia-induced TGF-β–RBFOX2–ESRP1 axis regulates human MENA alternative splicing and promotes EMT in breast cancer
por: Ahuja, Neha, et al.
Publicado: (2020) -
Novel Alternatively Spliced Variants of Smad4 Expressed in TGF-β-Induced EMT Regulating Proliferation and Migration of A549 Cells
por: Wan, Rongxue, et al.
Publicado: (2020) -
TGF-β in developmental and fibrogenic EMTs
por: Lee, Jun Ho, et al.
Publicado: (2022) -
TGF-β1 Induced Transdifferentiation of RPE Cells is Mediated by TAK1
por: Dvashi, Zeev, et al.
Publicado: (2015) -
Angiotensin Inhibition, TGF-β and EMT in Cancer
por: Pallasch, Fabian Bernhard, et al.
Publicado: (2020)